Marcela M. Cordero Garcia

Array ( [id] => 7586434 [patent_doc_number] => 20110280944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'FIBROUS MICROCAPSULES AND METHODS OF ASSEMBLY AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/109186 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5154 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280944.pdf [firstpage_image] =>[orig_patent_app_number] => 13109186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571718 [patent_doc_number] => 08338363 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Pharmaceutical compositions comprising casein derived peptides and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/107331 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 20499 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13107331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446283 [patent_doc_number] => 08288335 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'ApoE analogs and methods for their use' [patent_app_type] => utility [patent_app_number] => 13/096423 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 42 [patent_no_of_words] => 47142 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13096423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792665 [patent_doc_number] => 20130109634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'Casein Peptide For Use In The Treatment Of Uterine Infections' [patent_app_type] => utility [patent_app_number] => 13/641959 [patent_app_country] => US [patent_app_date] => 2011-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11804 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9435910 [patent_doc_number] => 20140113817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-24 [patent_title] => 'PEPTIDES WITH ANTIMICROBIAL ACTIVITY, DRUG COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF ANIMALS, COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF PLANTS, USES OF SAID PEPTIDES, AND USES OF PAENIBACILLUS ELGIL OUROFINENSIS EXTRACT' [patent_app_type] => utility [patent_app_number] => 14/111707 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5414 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8062303 [patent_doc_number] => 20110245867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Haemostatic Kit, A Method of Preparing A Haemostatic Agent and a Method of Promoting Haemostatis' [patent_app_type] => utility [patent_app_number] => 13/082109 [patent_app_country] => US [patent_app_date] => 2011-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6694 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245867.pdf [firstpage_image] =>[orig_patent_app_number] => 13082109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290393 [patent_doc_number] => 20120178721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'IMMUNOMODULATORY COMPOUNDS AND TREATMENT OF DISEASES RELATED TO AN OVERPRODUCTION OF INFLAMMATORY CYTOKINES' [patent_app_type] => utility [patent_app_number] => 13/073737 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14394 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13073737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10549504 [patent_doc_number] => 09274124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Mass spectrometric assays for peptides' [patent_app_type] => utility [patent_app_number] => 13/635668 [patent_app_country] => US [patent_app_date] => 2011-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 17634 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574018 [patent_doc_number] => 20110269674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'SYNTHETIC OR NATURAL PEPTIDES BINDING PROTEIN PHOSPHATASE 2A, IDENTIFICATION METHOD AND USES' [patent_app_type] => utility [patent_app_number] => 13/040862 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8675 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269674.pdf [firstpage_image] =>[orig_patent_app_number] => 13040862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046542 [patent_doc_number] => 20110206637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'ANTIVIRAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/032942 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20506 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206637.pdf [firstpage_image] =>[orig_patent_app_number] => 13032942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783946 [patent_doc_number] => 20120045502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'ANTAGONISTS OF MUC1' [patent_app_type] => utility [patent_app_number] => 13/026858 [patent_app_country] => US [patent_app_date] => 2011-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26738 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045502.pdf [firstpage_image] =>[orig_patent_app_number] => 13026858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347829 [patent_doc_number] => 20120208761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'TYPE I-TYPE IV COLLAGEN HYBRID GEL' [patent_app_type] => utility [patent_app_number] => 13/027088 [patent_app_country] => US [patent_app_date] => 2011-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14654 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13027088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11226128 [patent_doc_number] => 09453845 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Mass spectroscopy analysis of mutant polypeptides in biological samples' [patent_app_type] => utility [patent_app_number] => 12/931445 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10197 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 273 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12931445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038481 [patent_doc_number] => 20110091530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'OLIGOPEPTIDE TYROSINASE INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/975030 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13345 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091530.pdf [firstpage_image] =>[orig_patent_app_number] => 12975030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8784686 [patent_doc_number] => 08431529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => 'Bi-dentate compounds as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/970813 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 13218 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12970813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8642623 [patent_doc_number] => 08367607 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Oxyntomodulin peptide analogue' [patent_app_type] => utility [patent_app_number] => 12/968382 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10764 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12968382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8240915 [patent_doc_number] => 20120149653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'MULTIFUNCTIONAL LINKERS AND METHODS FOR THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/968225 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16813 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12968225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725531 [patent_doc_number] => 08404647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Peptidylarginine deiminase (PAD) inhibitors' [patent_app_type] => utility [patent_app_number] => 12/965536 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 20800 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12965536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834161 [patent_doc_number] => 08449915 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-05-28 [patent_title] => 'Pharmaceutical composition of nanoparticles' [patent_app_type] => utility [patent_app_number] => 12/928279 [patent_app_country] => US [patent_app_date] => 2010-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 30 [patent_no_of_words] => 26477 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12928279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943443 [patent_doc_number] => 20110104063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'FLEXIBLY LABELING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/955575 [patent_app_country] => US [patent_app_date] => 2010-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6374 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104063.pdf [firstpage_image] =>[orig_patent_app_number] => 12955575 [rel_patent_id] =>[rel_patent_doc_number] =>)